Olema Pharmaceuticals, Inc. — Form D

Olema Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-12. The offering totals $250.0M, of which $250.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Sean Bohen, M.D., Ph.D.DirectorSan Francisco, CA
Cynthia C ButittaDirectorSan Francisco, CA
Ian L ClarkDirectorSan Francisco, CA
Scott L GarlandDirectorSan Francisco, CA
Cyrus L Harmon, Ph.D.DirectorSan Francisco, CA
Sandra L Horning, M.D.DirectorSan Francisco, CA
Gorjan L Hrustanovic, Ph.D.DirectorSan Francisco, CA
Yi C LarsonDirectorSan Francisco, CA
Andrew C RappaportDirectorSan Francisco, CA
Graham L Walmsley, M.D., Ph.D.DirectorSan Francisco, CA
Sean Bohen, M.D., Ph.D.Executive OfficerSan Francisco, CA
Shane C KovacsExecutive OfficerSan Francisco, CA
David C Myles, Ph.D.Executive OfficerSan Francisco, CA
Naseem C Zojwalla, M.D.Executive OfficerSan Francisco, CA
Gorjan HrustanovicDirectorSan Diego, CA
Frank McCormickDirectorPALO ALTO, CA
Frank McCormickExecutive OfficerPALO ALTO, CA
Ian ClarkDirectorSOUTH SAN FRANCISCO, CA
David MylesExecutive OfficerSalt Lake City, UT
Cynthia ButittaDirectorPrinceton, NJ
Marina BozilenkoDirectorHayward, CA
Sean BohenDirectorSTEVENAGE, HERTFORDSHIRE, X0
Sean BohenExecutive OfficerSTEVENAGE, HERTFORDSHIRE, X0
Peter KushnerExecutive OfficerSan Francisco, CA
Kinney HornExecutive OfficerSan Francisco, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2023-09-14D$130.0M$130.0M
2020-10-13D$87.4M$87.4M
2020-06-23D/A$55.4M$53.9M
2020-03-27D$45.0M$30.0M
2018-08-27D$6.1M$6.1M

More